Medtronic sees strong Q2 growth despite weak spine and no ICD improvement
This article was originally published in Clinica
Executive Summary
Medtronic today posted stronger-than-expected growth in both its top and bottom lines for its second fiscal quarter, beating analysts' forecasts.